Galantamine Hydrobromide was first derived from the Galanthus nivalis in
1956 by a Bulgarian chemist D. Pascov together with his team. Studies
on the Galantamine Hydrobromide uses in modern medicine date from 1950
when the Soviet Union was actively involved in them.
The active agent was then extracted, identified, and studies were done
on it. The research done was concerning the Galantamine Hydrobromide
acetylcholinesterase (AChE)-inhibiting properties. Later in 1959, the
first industrial process on this compound was carried out. In 2001, it
got approved by the FDA.
2. How does Galantamine Hydrobromide work?
The Galantamine Hydrobromide mechanism of action involves the
acetylcholinesterase activity which is involved in the destruction of
acetylcholine.
Acetylcholine is a vital neurotransmitter situated in the brain and
whose function is to aid in the communication between nerve cells. Once
there are reduced levels of acetylcholine in the body, one risks from
suffering from some of the Alzheimer’s disease symptoms.
Galantamine HBR works by blocking the enzyme that destroys
acetylcholine. Subsequently, there is an increase in the concentration
of acetylcholine in the brain hence improved thinking.
3. Galantamine Hydrobromide brand nameA Comprehensive Overview On Nootropic Supplements Galantamine Hydrobromide in 2019
Razadyne,
